Global and United States IVD Antibodies Market Report & Forecast 2022-2028

In vitro diagnostics tests are used in laboratories, healthcare settings or directly by consumers at home for the detection of various diseases, infections and other medical conditions. Various companies in the IVD antibodies market are focusing on mergers and acquisitions with regional players. For example, in Sep. 2018, Summa Equity AB acquired Turku-based HyTest Ltd. whose regional presence in the U.S. and Asia is good. Continuously evolving nature of IVD antibodies market further expected to get maximum traction. Superior capability of the IVD antibodies to detect complex diseases such as cancer and use of IVD antibodies in therapeutic monitoring, evaluating blood safety before transfusion further makes it preferred choice of diagnosis test.
Market Analysis and Insights: Global and United States IVD Antibodies Market
This report focuses on global and United States IVD Antibodies market, also covers the segmentation data of other regions in regional level and county level.
Due to the COVID-19 pandemic, the global IVD Antibodies market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period. Fully considering the economic change by this health crisis, by Type, Cardiac Markers accounting for % of the IVD Antibodies global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While by Application, Hospital was the leading segment, accounting for over percent market share in 2021, and altered to an % CAGR throughout this forecast period.
In United States the IVD Antibodies market size is expected to grow from US$ million in 2021 to US$ million by 2028, at a CAGR of % during the forecast period.
Global IVD Antibodies Scope and Market Size
IVD Antibodies market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global IVD Antibodies market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.
For United States market, this report focuses on the IVD Antibodies market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.
Segment by Type
Cardiac Markers
Tumor Markers
Kidney Injury Markers
Segment by Application
Hospital
Specialty Clinic
Diagnostic Center
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
By Company
Abcam
Thermo Fisher Scientific
Rockland Immunochemicals
GenScript
Bio-Rad Laboratories
SDIX
MEDICAL & BIOLOGICAL LABORATORIES
HyTest
Abbott